Serum Complement Component 4A and Neurofilament Light Chain Levels Before and After Risperidone Monotherapy in Patients With Psychosis.
OBJECTIVE Recently, complement component 4A (C4A), a complement system protein, and neurofilament light chain (NfL), a neuroaxonal injury biomarker, have been found to be potentially implicated in the pathophysiology of psychosis. This study evaluated C4A and NfL levels before and after risperidone monotherapy in patie...